Skip to main contentAccess keys help

[an error occurred while processing this directive]
BBC News
watch One-Minute World News
News imageNews imageNews image
News imageNews image
News image
News imageNews imageNews imageNews imageNews imageNews imageNews imageNews imageNews imageNews imageNews imageNews imageNews imageNews imageNews imageNews imageNews imageNews imageNews imageNews imageNews imageNews imageNews imageNews imageNews image
News imageNews imageIntroductionNews imageNews imageNews imageThe HIV virusNews imageNews imageNews imageInfectionNews imageNews imageNews imageEarly stagesNews imageNews imageNews imageAids developsNews imageNews imageNews imageAnti-HIV drugsNews imageNews image
News imageNews imageNews imageNews image
News image
News image
Since the start of the HIV epidemic, a series of drugs have been developed which significantly prolong the lives of people who are HIV positive

Called "antiretroviral drugs", they block the virus's ability to replicate.

They can delay the onset of Aids by slowing the loss of patients' CD4+ cells, but they are not a cure.

There are four main classes of drugs, operating at different points in the HIV cycle, as shown on the diagram on the right.

A wide range of side effects are associated with antiretroviral therapy.

Many patients experience nausea, vomiting, headaches, fatigue, rashes, diarrhoea, insomnia, stomach pain and numbness around the mouth.

Inflammation of the pancreas, damage to the liver and nerves, changes in body shape, anaemia and muscle pain can also result from some of the drugs.

Antiretroviral drugs should be taken in combination. Usually three different drugs, from at least two different classes, are used at once.

As HIV mutates, some versions of the virus become resistant to drugs. The chances of keeping it in check are therefore much higher if several drugs are used.

Pill-taking regimes can be complicated and involve taking tablets at very specific times during the day.

If such programmes are not followed properly, the likelihood of the virus growing resistant to the drugs increases.

Some people are now becoming infected with strains of the virus which are already resistant to particular drugs.

News image
HOW ANTI-HIV DRUGS WORK
News image
News image
Entry inhibitors bind to the proteins on the outside of the HIV virus and stop it from entering the target cell (Fuzeon only).
News image
Nucleoside reverse transcriptase inhibitors stop HIV copying its genes into the cell. Nucleosides are the building block for genes. The drugs supply faulty versions of these building blocks (drugs include abacavir, AZT, ddI, 3TC).
News image
Non-nucleoside reverse transcriptase inhibitors also block the gene-copying process. They disable the enzyme that controls it (drugs include nevirapine and efavirenz).
News image
Protease inhibitors disable protease, an enzyme which plays a key role in the formation of the new virus (drugs include amprenavir, lopinavir, ritonavir, nelfinavir).
News image
HIV GLOSSARY
What is a CD4+ CELL?
News image
News imageGuide to key HIV terms

PRODUCTS AND SERVICES

AmericasAfricaEuropeMiddle EastSouth AsiaAsia Pacific